12/27/2005 – The interventional medical device approaches first used to treat cardiovascular disorders have found uses in other surgical areas such as pulmonology. Acclarant Inc. has raised $28 million of Series B funding to bring some of these same techniques to the ear, nose and throat, or ENT, space, President and Chief Executive William Facteau said. [ full story ]
